Largo Reports Q1 2025 Production and Sales Results; Provides Update on Operational Turnaround Plans By Investing.comApril 24, 2025
Merck & Co. and Eisai Report Keytruda Plus Lenvima Study in Endometrial CancerBy topmanagerDecember 8, 20230 Merck & Co. and Eisai recently announced the outcome of a Phase 3 study investigating the use of Keytruda plus…
